tm logo
CUREVAC
Live/Registered
REGISTERED

on 13 Apr 2021

Last Applicant/ Owned by

FRIEDRICH-MIESCHER-STR. 15

TÜBINGEN

DE

72076

Serial Number

88602178 filed on 03rd Sep 2019

Registration Number

6318156 registered on 13th Apr 2021

in the Principal Register

Correspondent Address

Jennifer Fraser

DYKEMA GOSSETT PLLC

1301 K STREET, NW

SUITE 1100 WEST

WASHINGTON, DC 20005

Filing Basis

No Filing Basis

Disclaimer

NO DATA

CUREVAC

The mark consists of the stylized term "CUREVAC" with the term "CURE" appearing in orange, the term "VAC" appearing in blue, and with a blue curved line beginning at the letter "V", and extending to the right and below the wording. In the statement, line 2, "Paul-Ehrlich-Str. 15" should be deleted, and "Friedrich-Miescher-Str. 15" should be inserted. Chemical preparations for medical use, namelyRead More

Classification Information


Class [001]
Chemical Products


Chemical reagents and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes

Class [005]
Pharmaceutical Products


Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and cancer diseases, of tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of cancers, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements, namely, dietary food supplements; Peptide carrier molecules for association with a biological macromolecule, for medical use, namely, for use in facilitating delivery of a wide range of medicinal substances; Peptidic carrier molecule for preparing a pharmaceutical composition, namely, for medical use as a protein delivery preparation to expedite or improve delivery of a therapeutic macromolecule or prophylactic biological marcomolecule; Peptide carrier molecule, sold in combination with a biological macromolecule for preparing a pharmaceutical composition, namely, for medical use as a protein delivery preparation to expedite or improve delivery of a therapeutic drug or prophylactic drug

Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services and research, in particular scientific research for identification, testing and characterisation of biological macromolecules; medical testing services, namely, pre-clinical and clinical testing of macromolecules; scientific research in the nature of discovery of biological macromolecules; Laboratory services, related to custom manufacturing of pharmaceutical ingredients, for identification, testing and characterisation of biological macromolecules

Class [044]
Medical, Beauty & Agricultural Services


Medical and veterinary services, in particular for therapeutic and prophylactic treatment of cancer diseases, infectious diseases, autoimmune diseases or allergies; Medical and veterinary services for treating of hereditary disorders; Medical and veterinary services for protein or enzyme supplement therapy for therapeutic or prophylactic treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases and for treatment of endocrinological or metabolic disorders

Mark Details


Serial Number

No 88602178

Mark Type

No Service Mark

Attorney Docket Number

No 067249-0055

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.17.09 -

Curved line(s), band(s) or bar(s)

Description of Design Search

The mark consists of the stylized term "CUREVAC" with the term "CURE" appearing in orange, the term "VAC" appearing in blue, and with a blue curved line beginning at the letter "V", and extending to the right and below the wording.

Legal History


Show more

Status DateAction Taken
08th Mar 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
30th Sep 2021CORRECTION UNDER SECTION 7 ¿ PROCESSED
30th Sep 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30th Apr 2021TEAS SECTION 7 REQUEST RECEIVED
13th Apr 2021REGISTERED-PRINCIPAL REGISTER
26th Jan 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26th Jan 2021PUBLISHED FOR OPPOSITION
06th Jan 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17th Dec 2020APPROVED FOR PUB - PRINCIPAL REGISTER
17th Dec 2020EXAMINER'S AMENDMENT ENTERED